Neuroscience Letters

The rapid communication journal for the neurosciences.

Neuroscience Letters - ISSN 0304-3940
Source Normalized Impact per Paper (SNIP): 0.675 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 0.858 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Impact Factor: 2.173 (2018) Impact Factor:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
5 Year Impact Factor: 2.228 (2018) Five-Year Impact Factor:
To calculate the five year Impact Factor, citations are counted in 2016 to the previous five years and divided by the source items published in the previous five years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
Volumes: Volumes 714-739
Issues: 26 issues
ISSN: 03043940

Institutional Subscription

Sales tax will be calculated at check-out Price includes VAT/GST
eJournal
This journal does not feature personal pricing and is not available for personal subscription.

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Neuroscience Letters is devoted to the rapid publication of short, high-quality papers of interest to the broad community of neuroscientists. Papers in all areas of neuroscience - molecular, cellular, developmental, systems, behavioral, cognitive, and computational - will be considered for publication. Submission of laboratory investigations that shed light on disease mechanisms is encouraged.

Neuroscience Letters does not publish case reports; papers that are primarily devoted to psychological or philosophical questions, papers that use unvalidated methodology, or that fall outside of the realm of neuroscience will also not be published. In addition, please note:

  • Clinical research will not be considered, unless the study includes new experimental findings of interest to neuroscientists in general. Clinical studies will not be considered unless they teach a lesson about organization or function of the nervous system.
  • Research on natural products, alternative medicine (acupuncture, etc.) and "traditional medicine" are not appropriate for Neuroscience Letters and will not be considered.
  • Research that provides descriptive data but without a mechanistic link which is tested rigorously with experimental data, will not be considered.
  • Research using only cell lines, for example PC12 cells, will not be considered.